Apotex US News and Activities
Presence
Headquarters: United States (USA)
Acquisition, funding and merger involving Apotex.
- Apotex is now listed under ticker APTX. (posted on June 17 2026).
- Apotex has just announced a $1 Million fundraising (posted on June 10 2026).
- Apotex has filed its IPO. Its stock ticker will be APTX. (posted on June 10 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be APTX. (posted on May 30 2026).
- See more news about Apotex Hide news involving Apotex
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Apotex US
- Prashant Raykar, Director, Branded Specialty Business Development
- Lenny Marrero, Vice President, Finance, United States
- Michael Bohling, Vice President and General Manager, USA
Popular executive movements at Apotex
- Bina Gill has joined the company as Human Resources Director (posted on June 1 2026).
- Jeff Watson has joined the company as President and Chief Executive Officer (posted on March 31 2026).
- Allan Oberman who was President and Chief Executive Officer, becomes Director (posted on March 31 2026).
Click here to view some more movements at Apotex
Create your alert
to follow the executive moves at Apotex US.
Pharmaceuticals
Apotex has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- The new name of Stealth BioTherapeutics is Mighty Therapeutics. (posted on June 19 2026).
- Transcend has announced the acquisition of Otsuka America Pharmaceutical (posted on June 18 2026).
- Chiesi has announced the acquisition of Kalvista Pharmaceuticals (posted on June 18 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Apotex US
Social media about Apotex US
- Apotex US on Wikipedia, Google News & Yahoo Finance
- Apotex US on LinkedIn, X (Twitter) & YouTube
